194 related articles for article (PubMed ID: 15046183)
21. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation.
Eguchi Y; Mizuta T; Ishibashi E; Kitajima Y; Oza N; Nakashita S; Hara M; Iwane S; Takahashi H; Akiyama T; Ario K; Kawaguchi Y; Yasutake T; Iwakiri R; Ozaki I; Hisatomi A; Eguchi T; Ono N; Fujimoto K
Liver Int; 2009 Feb; 29(2):213-20. PubMed ID: 18710430
[TBL] [Abstract][Full Text] [Related]
22. Molecular evidence supporting the portal theory: a causative link between visceral adiposity and hepatic insulin resistance.
Kabir M; Catalano KJ; Ananthnarayan S; Kim SP; Van Citters GW; Dea MK; Bergman RN
Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E454-61. PubMed ID: 15522994
[TBL] [Abstract][Full Text] [Related]
23. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance and oxidative stress interdependency in non-alcoholic fatty liver disease.
Videla LA; Rodrigo R; Araya J; Poniachik J
Trends Mol Med; 2006 Dec; 12(12):555-8. PubMed ID: 17049925
[TBL] [Abstract][Full Text] [Related]
25. Spirulina improves non-alcoholic steatohepatitis, visceral fat macrophage aggregation, and serum leptin in a mouse model of metabolic syndrome.
Fujimoto M; Tsuneyama K; Fujimoto T; Selmi C; Gershwin ME; Shimada Y
Dig Liver Dis; 2012 Sep; 44(9):767-74. PubMed ID: 22444524
[TBL] [Abstract][Full Text] [Related]
26. Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines.
Kang L; Sebastian BM; Pritchard MT; Pratt BT; Previs SF; Nagy LE
Alcohol Clin Exp Res; 2007 Sep; 31(9):1581-8. PubMed ID: 17624994
[TBL] [Abstract][Full Text] [Related]
27. The treatment of NAFLD.
Trappoliere M; Tuccillo C; Federico A; Di Leva A; Niosi M; D'Alessio C; Capasso R; Coppola F; Dauria M; Loguercio C
Eur Rev Med Pharmacol Sci; 2005; 9(5):299-304. PubMed ID: 16231594
[TBL] [Abstract][Full Text] [Related]
28. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
Federico A; Trappoliere M; Loguercio C
Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
[TBL] [Abstract][Full Text] [Related]
29. Adipotoxicity and the insulin resistance syndrome.
Anderwald C; Roden M
Pediatr Endocrinol Rev; 2004 Mar; 1(3):310-9. PubMed ID: 16437024
[TBL] [Abstract][Full Text] [Related]
30. The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity.
Dyck DJ; Heigenhauser GJ; Bruce CR
Acta Physiol (Oxf); 2006 Jan; 186(1):5-16. PubMed ID: 16497175
[TBL] [Abstract][Full Text] [Related]
31. Treatment of insulin resistance in diabetes mellitus.
Lebovitz HE; Banerji MA
Eur J Pharmacol; 2004 Apr; 490(1-3):135-46. PubMed ID: 15094080
[TBL] [Abstract][Full Text] [Related]
32. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients.
Jan V; Cervera P; Maachi M; Baudrimont M; Kim M; Vidal H; Girard PM; Levan P; Rozenbaum W; Lombès A; Capeau J; Bastard JP
Antivir Ther; 2004 Aug; 9(4):555-64. PubMed ID: 15456087
[TBL] [Abstract][Full Text] [Related]
33. Meta-analysis: insulin sensitizers for the treatment of non-alcoholic steatohepatitis.
Rakoski MO; Singal AG; Rogers MA; Conjeevaram H
Aliment Pharmacol Ther; 2010 Nov; 32(10):1211-21. PubMed ID: 20955440
[TBL] [Abstract][Full Text] [Related]
34. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
[TBL] [Abstract][Full Text] [Related]
35. Current treatment of non-alcoholic fatty liver disease.
Ahmed MH; Byrne CD
Diabetes Obes Metab; 2009 Mar; 11(3):188-95. PubMed ID: 18564173
[TBL] [Abstract][Full Text] [Related]
36. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
Black PH
Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
[TBL] [Abstract][Full Text] [Related]
37. [Adipocytokins, obesity and development of type 2 diabetes].
Lacquemant C; Vasseur F; Leprêtre F; Froguel P
Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data.
Serfaty L; Capeau J
Liver Int; 2009 Mar; 29 Suppl 2():13-25. PubMed ID: 19187069
[TBL] [Abstract][Full Text] [Related]
39. [Adipose tissue: a real endocrine gland synthesizing hormones and cytokines: clinical implications].
Martin-Du Pan RC; Giusti V
Rev Med Suisse Romande; 2004 Mar; 124(3):171-5. PubMed ID: 15095664
[TBL] [Abstract][Full Text] [Related]
40. Review article: the treatment of fatty liver disease associated with the metabolic syndrome.
Marchesini G; Natale S; Manini R; Agostini F
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():37-9. PubMed ID: 16225470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
